Abcam plc (ABCM)

Abcam (AIM:ABC; NASDAQ:ABCM), a global innovator in life sciences reagents and tools, today announces the successful completion of its acquisition of BioVision and the expansion of its immunoassay capacity in Eugene, OR.

Companies Reporting Before The Bell • Optical Cable (NASDAQ:OCC) is expected to report earnings for its third ...

Abcam plc(NASDAQ: ABCM)has agreed to acquireBioVision Inc, a wholly-ownedBoai NKY Medical Holdings ...

ABCM, CCJ, EBMT, MRTN and NESR have been added to the Zacks Rank #5 (Strong Sell) List on July 29, 2021.

Before 10 a.m. ET Tuesday, 64 stocks made new 52-week lows. Key Facts: TotalEnergies (NYSE:TTE) was the ...

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100..

Headwaters Capital, an investment management firm, published its second quarter 2021 investor letter – a copy of which can be downloaded here. A quarterly portfolio net return of 8.3% was recorded by the fund for the second quarter of 2021, outperforming the Russell Mid Cap Index that delivered a 7.5% return for the same period. […]

Abcam (AIM: ABC) (NASDAQ: ABCM), a global innovator in life sciences reagents and tools, today announces the opening of a major new site in Waltham, MA.

The share price of Abcam plc ( LON:ABC ) has struggled to grow by much over the last few years and probably has to do...

Today Pionyr Immunotherapeutics, Inc., a company developing first-in-class antibody therapeutics that increase the body's anti-tumor immunity and Abcam (AIM: ABC) (NASDAQ: ABCM), a global innovator in life science reagents and tools, announced the extension of their collaboration with a new commercial licensing agreement to support the progression of PY314, the first to the clinic of Pionyr's compounds.

They provide the infrastructure and sell the tools that biomedical researchers need to make breakthroughs.

We often see insiders buying up shares in companies that perform well over the long term. On the other hand, we'd be...

Avacta Group plc (AIM: AVCT), the developer of innovative cancer therapies and diagnostics based on its proprietary Affimer® and pre|CISION™ platforms, is pleased to announce that it has entered into a global distribution agreement with ABCAM plc (AIM: ABC; NASDAQ: ABCM) to sell the Group’s recently developed SARS-CoV-2 research ELISA Affimer® reagents.

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100..

NEW YORK, NY / ACCESSWIRE / March 8, 2021 / Abcam Plc (NASDAQ:ABCM) will be discussing their earnings results in their 2021 First Half Earnings call to be held on March 8, 2021 at 2:00 PM Eastern Time.To listen to the event live or access a replay of the call - visit https://www.

In recent trading, shares of Abcam PLC (ABCM) have crossed above the average analyst 12-month target price of $22.67, changing hands for $22.74/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level..

The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...

Abcam returns to growth in first half with over 8% increase in constant currency revenue

Upgrades For International Paper Co (NYSE: IP), Citigroup upgraded the previous rating of Neutral to the current rating Buy. For ...